A major cause of cancer recurrence following chemotherapy is cancer dormancy escape.
Taxane-based chemotherapy is standard of care in breast cancer treatment aimed at killing …

摘要肿瘤转移的防治可显著改善实体瘤患者的生存, 然而目前临床上仍缺乏有效的转移防治药物
, 其根本原因是现有的干预措施和治疗药物都难以实现对转移的精准防治. 由于早期术后患者的 …

Background Recurrence after primary treatment is an important obstacle to the curing of
primary breast cancer. Less‐immunosuppressive anesthetic techniques, such as local …

Metastatic breast cancer can recur years after initial treatments and arise from quiescent
disseminated tumor cells (QDTC). To date there are no treatments to target QDTCs …

Dysregulation of Fibroblast Growth Factor Receptors (FGFRs) signaling has been
associated with breast cancer, yet employing FGFR-targeted delivery systems to improve …

Purpose Liver transplantation (LT) is the definite curative treatment for hepatocellular
carcinoma (HCC), but recurrence can occur even under stringent criteria.“Delayed” HCC …

Obwohl die meisten Brustkrebserkrankungen in einem heilbaren Stadium diagnostiziert
werden, kommt es bei etwa 20% der Frauen im Laufe ihres Lebens zu einem erneuten …

Breast Cancer (BC) has been a highly prevalent cause of morbidity and mortality in women.
The incidence of mortality rate in BC patients increases with age, in which nearly 95% of …

The leading cause of death among breast cancer patients is the recurrence of breast cancer
as a metastatic disease after primary tumor resection and adjuvant therapy. Accumulating …

The bone marrow tumor microenvironment (BMTE) is a complex network of cells,
extracellular matrix, and sequestered signaling factors that initially act as a hostile …